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Researchers and physicians have long proposed
that infection(s) might cause diverse childhood
leukemias. Several lines of scientiﬁc evidence
support the plausibility of these hypotheses but
definitive proof remains elusive. In this
overview we highlight the general rationale
behind proposals that one or more infections
determine or are important co-factors in the
development of childhood acute lymphoblastic
leukemia (ALL). We briefly outline existing
direct and indirect evidence for and against
these hypotheses and the challenges to proving
infectious causality, even in leukemia clusters.
Against a background of assertions that non-
microbial environmental exposures and other
factors cause ALL, this synopsis draws atten-
tion to the very plausible possibility that infec-
tion(s), perhaps in the context of multifactorial
or complex systems, do contribute to child-
hood ALL. We underscore the importance of
continuing to investigate whether potentially
preventable or treatable infections inﬂuence the
development of childhood ALL, particularly
common precursor B-cell ALL (cALL) but also
emphasizes the ongoing need for optimal study
design and detection tools in this effort.
Plausibility
Leukemias and lymphomas represent malig-
nant, clonal expansions of white blood cell
populations. Simplistically, white blood cells
act as the body’s primary defense against infec-
tions, where normal, regulated expansions of
lymphocytes, monocytes, and neutrophils neu-
tralize and eliminate pathogens. Therefore,
aberrant responses to infection(s) could lead to
leukemia through the abnormal proliferation
of immune cells or a failure to curb the malig-
nant expansion of an abnormal immune cell.
Direct infection of lymphocytes might induce
unchecked proliferation of a normal or a sus-
ceptible (preleukemic) lymphocyte to produce
ALL; either persistent infection or malignant
transformation triggered by past infection (one
cleared from the body some time before ALL is
diagnosed) is a conceivable route from direct
lymphocyte infection to ALL. Alternatively,
infection might indirectly induce ALL by stim-
ulating an overly robust or poorly regulated
immune response that would otherwise be
protective. Last, other plausible hypotheses
suggest that certain patterns of microbial expo-
sure might actually protect against an abnor-
mal lymphocyte proliferation that develops
into ALL. 
Most childhood leukemias are diagnosed
under the age of 8 years, with reports of peak
incidences ranging from 2–3 years to
2–5 years [McNally et al. 2003; Ries et al.
1999; Surveillance Epidemiology and End
Results (SEER) 2005; U.S. Cancer Statistics
Working Group 2005]; cALL accounts for
most of these cases. Similarly, many common
viral and bacterial infections, including some
vaccine preventable infections, occur during
early childhood, also exposing susceptible
infants, older children, and pregnant mothers
(Fleming et al. 1987; Louhiala et al. 1995).
Such overlapping age patterns of childhood
infection and peak incident cALL suggest that
one or more infectious agents might promote
childhood cALL. Although observations of
higher childhood cALL rates in established
economies and higher socioeconomic groups
with lower burdens of childhood infection
might contradict this idea, a number of
immune and demographic factors, such as
delayed infection, could reconcile the noted
inconsistencies. 
In this vein, cALL could represent a rela-
tively rare response to one or more common
childhood infections. Only some of many
infected children would be at risk for the
abnormal immunologic response, acute
lymphoblastic leukemia. Age at infection (e.g.,
very early in life or later than most of the popu-
lation), preceding or concurrent environmental
exposures, and even the child’s cumulative
number and types of infections might play crit-
ical roles in determining which children ulti-
mately develop cALL. For example, infections
early in life might increase or decrease leukemia
risk, respectively, by either triggering malignant
proliferation or ensuring normal immune
development so that later infectious exposures
do not produce aberrant lymphoproliferative or
immune-mediated syndromes (Bach 2005;
Greaves 1988, 1997, 2000). 
Alternatively, uncommon or rare agents
might induce cALL in many of the small
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Infections as well as environmental exposures are proposed determinants of childhood acute
lymphoblastic leukemia (ALL), particularly common precursor B-cell ALL (cALL). Lines of investiga-
tion test hypotheses that cALL is a rarer result of common infection, that it results from uncommon
infection, or that it ensues from abnormal immune development; perhaps it requires a preceding pre-
natal or early childhood insult. Ideally, studies should document that particular infections precede
leukemia and induce malignant transformation. However, limited detection studies have not directly
linked speciﬁc human or nonhuman infectious agents with ALL or cALL. Primarily based on surro-
gate markers of infectious exposure, indirect evidence from ecologic and epidemiologic studies varies
widely, but some suggest that infancy or early childhood infectious exposures might protect against
childhood ALL or cALL. Several others suggest that maternal infection during pregnancy might
increase risk or that certain breast-feeding practices decrease risk. To date, evidence cannot conﬁrm or
refute whether at least one infection induces or is a major co-factor for developing ALL or cALL, or
perhaps actually protects against disease. Differences in methodology and populations studied may
explain some inconsistencies. Other challenges to proof include the likely time lag between infection
and diagnosis, the ubiquity of many infections, the inﬂuence of age at infection, and the limitations in
laboratory assays; small numbers of cases, inaccurate background leukemia rates, and difﬁculty track-
ing mobile populations further affect cluster investigations. Nevertheless, existing evidence partially
supports plausibility and warrants further investigation into potential infectious determinants of ALL
and cALL, particularly in the context of multifactorial or complex systems. Key words: ALL, cALL,
childhood acute lymphoblastic leukemia, common precursor B-cell ALL, infection, leukemia, virus.
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[Online 30 November 2006]numbers of infected children—existing stud-
ies simply may not have detected these
microbes or not yet associated them with dis-
ease. Current scientiﬁc evidence cannot con-
firm or refute either scenario. For both, it
remains unclear whether infection would
need to occur after birth, before birth, or if
infection during either time period could
elicit acute leukemia. 
Certain features of microbes reinforce the
plausibility of these postulates. Human, ani-
mal model, and in vitro studies demonstrate
that some viruses can incorporate into the
human genome, persist in an episomal state,
or alter crucial intracellular functions. In vitro,
Epstein-Barr virus (EBV) transforms B-lym-
phocytes, creating immortalized cell lines.
Intuitively, then, EBV might be capable of
inducing B-lymphocyte malignancies such as
cALL. However, although a number of studies
have associated EBV infection or infectious
mononucleosis with solid lymphoproliferative
tumors, none have yet linked the virus with
leukemia. Irrefutable evidence does confirm
that the nonhuman retroviruses avian leukosis
virus (ALV), bovine leukemia virus (BLV),
feline leukemia virus (FeLV), and murine
leukemia virus (MuLV) induce lympho-
proliferative disease in birds, cattle, cats, and
mice, respectively; all are usually associated
with T-cell leukemias. Nevertheless, investiga-
tors have never detected FeLV, ALV, BLV,
or natural MuLV infection in humans
(Klein 2002). 
In humans, molecular and immunologic
assays can not only detect human T-cell lym-
photropic virus type 1 (HTLV-1) in the malig-
nant cells of adult T-cell leukemia/lymphoma
(ATLL) but, preceding the development of
ATLL, detect the virus in lymphocytes as well
as serum antibodies to HTLV-1 (Blattner and
Charurat 2005; Centers for Disease Control
and Prevention 1993). Epidemiologic studies
demonstrate an increased risk for ATLL in
HTLV-1 endemic areas, particularly following
perinatal infection. In vitro studies further
reveal that the viral protein Tax can transform
or immortalize lymphocytes (Mahieux and
Gessain 2003). Yet, ATLL develops in < 5% of
individuals infected with HTLV-1 (Blattner
and Charurat 2005), and the factor deﬁning
which few acquire ATLL remains unclear. If,
similarly, cALL occurs in a small percentage of
children infected with one or more as yet
unconfirmed etiologic microbial agent(s),
proving the causal association may be difﬁcult. 
Laboratory and epidemiologic evidence
also link EBV infection to subsets of Hodgkin
disease/Hodgkin lymphoma (HD), a solid
tumor malignancy of lymphocytes (Chang
et al. 2004a, 2004b, 2005; Glaser et al. 2005;
Hjalgrim et al. 2003; Kanzler et al. 2000;
Mueller et al. 1989; O’Connor and Scadden
2000). Generally, published molecular analyses
have detected the EBV genome in up to 80%
of the mixed cellular HD and up to 40–50%
of all HD cases examined, but estimates of
EBV-infected malignant cells range to > 90%.
Although questions on causality remain, some
reports have speciﬁcally associated HD with a
history of EBV-induced infectious mononu-
cleosis, smaller families, or higher socio-
economic status (SES) (Chang et al. 2004a,
2004b; Glaser et al. 2005). 
Burkitt lymphoma, however, was the pre-
lude to all conﬁrmed and proposed infectious
etiologies of cancers, including childhood
leukemias. Epidemiologic data and detection
of the virus in tumors consistently implicated
EBV as the viral etiology of Burkitt lymphoma
in specific regions of sub-Saharan Africa.
Although some researchers have recently chal-
lenged whether EBV actually induces tumori-
genesis, the long-standing association is clear
(Johannsen et al. 2005; Niller et al. 2004;
Thorley-Lawson and Gross 2004).
Given these examples, researchers have
actively pursued the possibility that childhood
or maternal/in utero infections during preg-
nancy influence a child’s risk for developing
cALL. In 1988, Greaves proposed that
reduced exposure to infectious agents during
infancy and early childhood might lead to
childhood leukemia; essentially, delayed
infectious exposure (e.g., lack of child care,
small families and/or higher socioeconomic
groups) would increase a child’s risk of devel-
oping cALL (Gilham et al. 2005; Greaves
1988, 1997, 2000; McNally and Eden 2004).
At the same time, Kinlen proposed that a
large influx of people into relatively isolated
communities (population mixing) might pro-
duce mini-epidemics among the previously
isolated, immunologically naïve and still sus-
ceptible children (Kinlen 1988). The resulting
increased exposure of the host population to
common or uncommon, potentially leuke-
mogenic infectious agents circulating in the
arriving population, might generate increased
numbers of leukemia cases over a defined
period (Gilham et al. 2005; Kinlen 1988,
1995, 2004; McNally and Eden 2004). While
distinct, the two hypotheses would be compati-
ble if an excess of the rarer response, ALL, sim-
ply occurs when population mixing exposes a
naïve cohort of children to infection at an
older age (Gilham et al. 2005). Although ini-
tially proposed for situations specific to the
United Kingdom, the cornerstones of these
hypotheses are relevant to the long-standing,
everyday travel and migration patterns inside
and across U.S. borders, reduced childhood
infections in established economies, increasing
global migration, and rising SES in developing
or middle-income economies. 
Greaves and others also hypothesized that
the malignant transformation of a normal cell
to leukemia cells requires two separate events,
initial priming followed at some point by a sec-
ondary incident (Gilham et al. 2005; Greaves
1997, 2000; McNally and Eden 2004; Smith
1997). For example, an in utero event (e.g.,
chromosomal damage induced by maternal
environmental exposure or infection; tri-
somy 21) might produce damaged or pre-
leukemic cells (Canﬁeld et al. 2004; Greaves
1997, 2000; Salomons et al. 1998; Smith 1997;
Wiemels et al. 1999a, 1999b, 2001). Later, a
postnatal or childhood infectious or environ-
mental exposure, perhaps a common infection,
induces leukemia only in those children made
susceptible by the primary event.
The preceding hypotheses emphasize that
patterns of delayed or unusual childhood infec-
tions might interfere with the proper matura-
tion or control of immune cells, producing
unchecked, aberrant lymphoproliferation when
infection does occur. Interestingly, though,
other plausible hypotheses suggest that multi-
ple early infectious exposures might benefit
immune development so that later infectious
exposures do not trigger aberrant responses, a
concept also discussed in the context of
immune-mediated syndromes and allergic con-
ditions (Bach 2005). This small body of litera-
ture awaits expansion and further testing. 
Direct Evidence for 
Infectious Etiology
At this time, no reports have identified any
speciﬁc infectious agent, common or rare, as a
cause or co-determinant of childhood ALL or
cALL. Only a limited number of published
investigations have directly assayed pretreat-
ment specimens for infectious agents at the
time of cALL diagnosis and few have retro-
spectively analyzed archived prediagnostic
specimens. More specifically, several small
studies failed to detect the human poly-
omaviruses JC virus and BK virus in leukemia
cells or stored newborn (Guthrie) blood spots
(MacKenzie et al. 1999; McNally and Eden
2004; Perzova et al. 2000; Priftakis et al.
2003; Smith et al. 1999); one also failed to
detect simian virus 40 (Smith et al. 1999).
Similarly, a few case–series and case–control
studies failed to associate select human her-
pesviruses or human parvovirus B19 with the
diagnosis of ALL (Bogdanovic et al. 2004; Isa
et al. 2004; Luppi et al. 1998; MacKenzie
et al. 2001; McNally and Eden 2004;
O’Connor and Scadden 2000). Most recently,
using representational difference analysis one
group of investigators detected no speciﬁc viral
sequences in pretreatment blood or bone mar-
row leukemic cells from a small number of
child and adolescent cALL cases (MacKenzie
et al. 2006). 
A small number of surveys have also used
surrogate measures of animal exposure, such as
pet ownership or animal care, to link zoonotic
infections with human lymphoproliferative
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et al. 1995; Sordillo et al. 1982). To date, no
non-human viruses, retroviruses, or bacteria
are associated with naturally occurring human
leukemia or lymphoma. It is worth noting,
however, that an adverse event of gene therapy
raised questions; 2 of 10 children with severe
combined immune deﬁciency (SCID) devel-
oped an uncontrolled clonal T-cell prolifera-
tion 30 to 34 months after experimental
retroviral gene therapy with the MuLV vector
(Hacein-Bey-Abina et al. 2003). Interestingly,
the T-cell clones of both cases demonstrated
vector integration near the hematopoietic pro-
tooncogene promoter of the LMO2 locus, a
point insertion rate higher than would be
expected with random viral integration.
Extensive investigation of these cases, how-
ever, detected no replication-competent retro-
virus in any cells tested. The investigators
concluded that the insertion likely deregulated
normal hematopoiesis. It is important that
although immune deficiency itself has not
been noted as a risk factor for ALL or cALL,
medical experiences not infrequently ﬁnd that
immunodeficient or immunocompromised
states, including SCID, may predispose indi-
viduals to develop lymphoproliferative solid
tumors (Biggar et al. 2000). 
Indirect Evidence for 
Infectious Etiology
Indirect evidence that infections cause or are
co-factors in the development of childhood
ALL is inconclusive, but much suggests that
infectious exposures do inﬂuence a child’s risk
for ALL or cALL. Briefly outlined here, a
number of reviews and reports summarize
studies that have attempted to test, prove, or
refute infectious determinants of childhood
leukemias, particularly cALL (Gilham et al.
2005; Greaves 1997, 2000; Kinlen 1995,
1997, 2004; McNally and Eden 2004; Smith
1997; Smith et al. 1998). Of note, however,
very few investigations have directly assayed
for active infection, or even past exposure to
specific childhood infections (at some time
preceding the leukemia diagnosis). Not all
have adjusted for confounders of infectious
exposure, such as SES.
In general, the results of published epi-
demiologic and ecologic studies vary, some
supportive but others contradictory or incon-
clusive. Unique characteristics of the diverse
populations studied might account for real dif-
ferences in the ﬁndings. Insufﬁcient power, dif-
ferent methodologies, and design weaknesses
explain other inconsistencies. Most are retro-
spective, including the population-based obser-
vations and case–control studies. To link
infection with childhood acute leukemias,
analyses have compared the incidence or preva-
lence of disease with the following factors:
patterns of infection and settings of frequent
exposure to infections; patterns of seasonality
in the diagnosis of leukemia; time–space clus-
tering of leukemia cases; risk factors for
increased susceptibility to childhood infections
(e.g., lower immunization rates); factors pro-
tecting from infection (e.g., breast-feeding);
population density or changes in population
density; and differences in SES. 
Primarily using surrogate markers for the
likelihood of childhood infection (e.g., daycare
attendance, number of siblings, contact with
father’s workplace, lower SES, less breast-
feeding, seasonality) but occasionally analyzing
documented clinical syndromes (e.g., ear
infection), a number of population-based and
smaller epidemiologic studies have now associ-
ated delayed or reduced childhood infections
with increased risk of childhood leukemia,
ALL or cALL (Chan et al. 2002; Gilham et al.
2005; Guise et al. 2005; Infante-Rivard et al.
2000; Jourdan-Da Silva et al. 2004; Ma et al.
2002; McKinney et al. 1999; McNally and
Eden 2004; McNally et al. 2003; Perrillat
et al. 2002; Petridou et al. 1993; Schüz et al.
1999; Smith et al. 1998; van Steensel-Moll
et al. 1986). Yet the speciﬁc variables associ-
ated with increased risk are often inconsistent,
varying between studies; even within single
studies, certain markers of infectious exposure
are associated with increased leukemia risk,
but different markers of similar exposure are
not. A few contradictory reports found no
increased risk of ALL or cALL with (markers
of) reduced or delayed infectious exposures,
and some actually described higher risk with
more infectious exposures (Chan et al. 2002;
Dockerty et al. 1999; Guise et al. 2005;
Infante-Rivard et al. 2000; Neglia et al. 2000;
Rosenbaum et al. 2000; Schüz et al. 1999).
Certain findings also vary—between and
within studies—by the type of leukemia and
the child’s age at diagnosis. Perhaps consistent
with both single- and two-event hypotheses of
causation, a limited number of studies and
reviews have suggested that maternal infection
during pregnancy might increase a child’s risk
for developing leukemia (Lehtinen et al. 2003;
McKinney 1999 et al; McNally and Eden
2004; Naumburg et al. 2002; Smith 1997;
Smith et al. 1999). 
Multiple, but not all, ecologic studies have
correlated indicators of population mixing and
increased population density with increased
rates of childhood leukemia (Alexander et al.
1997, 1999; Chan et al. 2002; Gilham et al.
2005; Greaves 1988, 1997, 2000; Hjalmars
and Gustafsson 1999; Kinlen 1988, 1995,
1997, 2004; Koushik et al. 2001; McNally and
Eden 2004; Ross et al. 1999). Of note, how-
ever, retrospective post-hoc analyses have dom-
inated this challenging hypothesis testing, often
having to extrapolate from limited population
and migration records and assuming uncon-
ﬁrmed patterns of infection transmission and
susceptibility. Others have examined seasonal
excesses in childhood leukemia or ALL
(Badrinath et al. 1997; Dockerty et al. 1999;
Fekety and Carey 1969; Gilman et al. 1998;
Thorne et al. 1998). Mostly retrospective and
with varying results, only some describe sea-
sonal, space–time, or population density clus-
tering and none tested for specific infectious
agents (Fekety et al. 1969; Gilman et al. 1999;
Gunze and Spears 1968; Gustafsson and
Carstensen 1999; Lee 1962). 
Other indirect evidence variably suggests
that infection(s) might inﬂuence the develop-
ment of childhood ALL. For example, a few
investigators have separately examined the
effects of vaccination in the U.S. and Finland.
The results suggested that immunization
against Haemophilus inﬂuenzae type b, particu-
larly during infancy, might reduce the risk of
developing childhood ALL (Groves et al.
1999, 2000). Examining small numbers of
childhood ALL cases and non-cases, a few
reports have also described potential HLA
haplotype differences that might affect suscep-
tibility to infection (Dorak et al. 2002; Taylor
et al. 1998).
Overall, widely varying and inconclusive
indirect evidence still suggests that infectious
exposures do alter a child’s risk for developing
ALL. In particular, a level of exposures during
infancy and early childhood might protect
against childhood ALL. Yet contrasting evi-
dence also suggests that certain types of infec-
tions, or infection at certain ages or stages of
development, might increase the risk of devel-
oping childhood ALL, particularly cALL.
Unique Challenges to Proof
Studies seeking to prove that one or more
infectious agents contribute to the develop-
ment of childhood ALL or cALL face numer-
ous challenges. Ideally, results should
document that a particular infection (or infec-
tious syndrome) precedes the development of
leukemia and directly causes (as a primary or
secondary factor) the malignant transformation
(Knobler et al. 2004). However, only a small
portion of the population ever develops child-
hood ALL. Coupled with limitations in detec-
tion assays and the difﬁculty of prospectively
and sequentially screening sufﬁcient numbers of
healthy children for preleukemic cells and acute
infectious exposures, this characteristic impedes
investigations. Therefore, most studies test for
infectious agents or past infectious exposures at
or after the time of diagnosis. That may be too
late to deﬁnitively correlate a speciﬁc infection
with development of ALL, particularly ubiqui-
tous infections that infect many children at a
young age. Detecting the responsible agent dur-
ing diagnosis requires that it persist in the tested
tissue(s) and that sensitive and speciﬁc detection
assays for that agent exist and be correctly
employed. Causally linking the agent to
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greater frequency in cases than in children who
do not develop leukemia, unlikely if much of
the population is infected during early child-
hood. On the other hand, detecting an infec-
tious agent in the setting of leukemia does not
prove that it caused disease, and failure to
detect an agent does not preclude that it
induced or promoted the ALL. Posing other
investigational challenges, different infectious
agents might induce the same abnormal clini-
cal outcome, childhood acute leukemia,
through converging pathways of pathogenesis.
Conﬁrming causality for each could be difﬁ-
cult. When infection is a critical co-factor (i.e.,
with environmental exposures or genetics) but
not the single cause of leukemogenesis, analyses
that focus only on one risk factor may never
associate ALL or cALL with infectious etiology. 
Childhood leukemia clusters pose addi-
tional investigational challenges. If the avail-
able background cancer rates are inaccurate, it
is impossible to reliably identify an excess of
leukemia cases or increased leukemia rates.
Clusters are usually small, limiting the power
of statistical analyses. Investigations are usu-
ally retrospective because the cluster is identi-
ﬁed only after someone suspects that an excess
number of cases have accumulated over a
defined period of time. At that point, most
cluster cases have already undergone treat-
ment and many are in remission. Ideally they
have no remaining leukemic cells, the cells
most likely to harbor a persistent etiologic
infectious agent. Indirect markers of past or
present infection obtained during the cluster
investigation can rarely conﬁrm that infection
preceded the diagnosis of leukemia, and retro-
spective histories inherently have recall bias.
Long characteristic of the United States but
perhaps increasingly so in other global
regions, a highly mobile population with few
means to track health care and exposure
histories, along with a paucity of large, popu-
lation-based longitudinal data sets and speci-
men collections, make testing the population
mixing hypothesis difficult, particularly in
cluster investigations.
Conclusions
Collectively, the existing scientific data con-
tinue to suggest that infection plays a critical
role in the development of childhood ALL
and cALL, perhaps in conjunction with other
risk factors. However, no speciﬁc microbes—
viruses, retroviruses, or bacteria—are defini-
tively associated with disease. Nevertheless,
enough direct and indirect evidence correlates
ALL or cALL with surrogates of infection or
even protection from infection to warrant
continued investigations. 
The key to future investigations may be in
complex systems of multifactorial disease
(O’Connor et al. 2006), where infection(s)
directly or indirectly causes childhood ALL in
susceptible individuals—genetically susceptible
or made susceptible by causal co-factors such as
environmental exposures. The application of
improved microbial detection assays, particu-
larly for viral agents, to well-designed studies of
sufﬁcient size and timing is needed to reliably
link preceding infection with subsequent
leukemia. The comprehensive analysis of well-
characterized pretreatment specimens from
larger numbers of childhood ALL cases and
their families (genetically and probably expo-
sure similar) and well-matched controls could
begin to correlate ALL with differences in
infectious exposures and other risk factors.
However, such studies might fail to identify a
critical role for past infections (not persistent at
the time of diagnosis) in the pathogenesis of
ALL. Though costly, large prospective cohort
studies that follow children and store serial
specimens from birth—perhaps with paired
maternal pregnancy specimens—might retro-
spectively or prospectively be able to correlate
past or present, uncommon or common infec-
tions with age at exposure, proximity of expo-
sure to ALL diagnosis, and early pre-leukemic
markers. When employing optimal study
design and improved detection tools, both
types of studies could help elucidate whether
preventing or treating certain infections might
avoid a portion of childhood ALL, particularly
cALL. Alternatively, such studies might
uncover whether early infectious exposures are
needed to promote a normally functioning
immune system and minimize aberrant lym-
phoproliferative responses such as ALL.
Answers to these questions remain important
to promoting child health. 
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